Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gorry

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Technology Assessment in Health Care|June 2, 2017
HEALTH TECHNOLOGY ASSESSMENT: THE SCIENTIFIC CAREER OF A POLICY CONCEPTCyril Benoit, Philippe Gorry
Archives of Oral Biology|July 25, 2007
A study of polymorphism in human AMELXBéatrice Richard, Sidney Delgado, Philippe Gorry, et al.
Biochemical and Biophysical Research Communications|February 1, 2002
Proteolipidic vectors for gene transfer to the lungLaurence Vaysse, Christine Guillaume, Ingrid Burgelin, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38Virginie Charasson, Ricardo Bellott, Delphine Meynard, et al.
International Journal of Molecular Medicine|April 6, 2006
Mutation in exon 7 of PTCH deregulates SHH/PTCH/SMO signaling: possible linkage to WNTVesna Musani, Philippe Gorry, Aleksandra Basta-Juzbasic, et al.
The Journal of Investigative Dermatology|August 20, 2003
Spectrum of PTCH1 mutations in French patients with Gorlin syndromeNathalie Boutet, Yves-Jean Bignon, Valérie Drouin-Garraud, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
The common fragile site FRA16C does not map within the 16q smallest region of overlap number 2 frequently lost in breast carcinomaLaurence Taine, Philippe Rocca-Serra, Azza Abd El Moneim, et al.
European Journal of Human Genetics : EJHG|May 3, 2007
Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patientsMarianne Stef, Delphine Simon, Béatrice Mardirossian, et al.
The Lancet. Neurology|June 8, 2015
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Mathieu Bourdenx, Philippe Gorry, et al.
Annals of Neurology|August 19, 2007
COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and strokeIgor Sibon, Isabelle Coupry, Patrice Menegon, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Technology Assessment in Health Care|June 2, 2017
HEALTH TECHNOLOGY ASSESSMENT: THE SCIENTIFIC CAREER OF A POLICY CONCEPTCyril Benoit, Philippe Gorry
Archives of Oral Biology|July 25, 2007
A study of polymorphism in human AMELXBéatrice Richard, Sidney Delgado, Philippe Gorry, et al.
Biochemical and Biophysical Research Communications|February 1, 2002
Proteolipidic vectors for gene transfer to the lungLaurence Vaysse, Christine Guillaume, Ingrid Burgelin, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38Virginie Charasson, Ricardo Bellott, Delphine Meynard, et al.
International Journal of Molecular Medicine|April 6, 2006
Mutation in exon 7 of PTCH deregulates SHH/PTCH/SMO signaling: possible linkage to WNTVesna Musani, Philippe Gorry, Aleksandra Basta-Juzbasic, et al.
The Journal of Investigative Dermatology|August 20, 2003
Spectrum of PTCH1 mutations in French patients with Gorlin syndromeNathalie Boutet, Yves-Jean Bignon, Valérie Drouin-Garraud, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
The common fragile site FRA16C does not map within the 16q smallest region of overlap number 2 frequently lost in breast carcinomaLaurence Taine, Philippe Rocca-Serra, Azza Abd El Moneim, et al.
European Journal of Human Genetics : EJHG|May 3, 2007
Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patientsMarianne Stef, Delphine Simon, Béatrice Mardirossian, et al.
The Lancet. Neurology|June 8, 2015
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Mathieu Bourdenx, Philippe Gorry, et al.
Annals of Neurology|August 19, 2007
COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and strokeIgor Sibon, Isabelle Coupry, Patrice Menegon, et al.
Pageof 2